Orrin Hatch actually said...

Has FDA analyzed, No. 1, the extent to which these cost of changing names is passed on to healthcare payers and consumers?

There are a lot of tradeoffs in the naming convention.

I'm very pleased with what you do over there, and I'm particularly pleased with what you're doing in this area.

I am concerned, as a taxpayer, with the breaches that we have had.